| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA2D1 PSG2 ABCA13 SLC38A9 TRPC4 TRPC5 CEACAM7 SIDT1 HTR3C TMC4 GRIN1 SLC35E2B CALHM3 GRM7 AQP4 SLC40A1 SVOPL ITPR2 SLC5A5 SLC41A2 SLC22A9 ATP1B4 SLC8B1 CLCA1 CLCN7 ABCA6 TRPM3 SLC20A2 SLC16A14 SLC5A6 SLC22A3 SLC35A2 SCN7A SLC49A4 SCN9A SLC28A1 SLC35F6 OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 3.33e-19 | 1180 | 173 | 47 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA2D1 PSG2 ABCA13 SLC38A9 TRPC4 TRPC5 CEACAM7 SIDT1 HTR3C TMC4 GRIN1 SLC35E2B CALHM3 GRM7 AQP4 SLC40A1 SVOPL ITPR2 SLC5A5 SLC41A2 SLC22A9 ATP1B4 SLC8B1 CLCA1 CLCN7 ABCA6 TRPM3 SLC20A2 SLC16A14 SLC5A6 SLC22A3 SLC35A2 SCN7A SLC49A4 SCN9A SLC28A1 SLC35F6 OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G ABCG2 ABCD1 ABCC2 RFT1 SLC51A SLC38A6 | 1.96e-18 | 1289 | 173 | 48 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 GRM7 AQP4 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 CLCA1 CLCN7 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 4.22e-10 | 758 | 173 | 27 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 GRM7 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC8B1 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 KCNQ2 CACNA1H CACNA1G | 6.90e-10 | 465 | 173 | 21 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 GRM7 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC8B1 CLCA1 CLCN7 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G | 1.13e-09 | 793 | 173 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 GRM7 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 OTOP1 KCNQ2 CACNA1H CACNA1G | 5.48e-09 | 627 | 173 | 23 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 HTR3C GRIN1 CALHM3 GRM7 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC8B1 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 OTOP1 KCNQ2 CACNA1H CACNA1G | 1.59e-08 | 664 | 173 | 23 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA2D1 TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 GRM7 ITPR2 CLCA1 CLCN7 TRPM3 SCN7A SCN9A OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G | 1.93e-08 | 459 | 173 | 19 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA2D1 TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 GRM7 AQP4 ITPR2 CLCA1 CLCN7 TRPM3 SCN7A SCN9A OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G | 3.17e-08 | 525 | 173 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 GRM7 AQP4 ITPR2 CLCA1 CLCN7 TRPM3 SCN7A SCN9A OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G | 3.27e-08 | 526 | 173 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 GRM7 ITPR2 SLC8B1 TRPM3 CACNA1H CACNA1G | 8.45e-08 | 151 | 173 | 11 | GO:0015085 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 GRM7 ITPR2 TRPM3 CACNA1H CACNA1G | 1.86e-07 | 129 | 173 | 10 | GO:0005262 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG2 SLC38A9 CEACAM7 GRIN1 SLC22A9 SLC16A14 SLC5A6 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 2.64e-07 | 207 | 173 | 12 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG2 SLC38A9 CEACAM7 GRIN1 SLC22A9 SLC16A14 SLC5A6 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 2.78e-07 | 208 | 173 | 12 | GO:0005342 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA2D1 TRPC4 TRPC5 HTR3C GRIN1 CALHM3 GRM7 ITPR2 TRPM3 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G | 3.24e-07 | 343 | 173 | 15 | GO:0005261 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.14e-06 | 90 | 173 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA2D1 HTR3C TMC4 GRIN1 CALHM3 GRM7 ITPR2 CLCA1 CLCN7 SCN7A TMEM266 KCNQ2 CACNA1H CACNA1G | 1.34e-06 | 334 | 173 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | PSG2 SLC38A9 CEACAM7 GRIN1 SLC22A9 SLC16A14 SLC5A6 SLC22A3 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 1.74e-06 | 293 | 173 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC5A5 SLC8B1 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A SLC28A1 CACNA1H CACNA1G | 2.49e-06 | 171 | 173 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA13 SLC35E2B SLC5A5 SLC22A9 SLC8B1 CLCN7 ABCA6 SLC20A2 SLC16A14 SLC5A6 SLC22A3 SLC35A2 SLC28A1 ABCG2 ABCD1 ABCC2 | 4.23e-06 | 477 | 173 | 16 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADGRG5 XCR1 OR2AK2 GPR17 OR1B1 OR4D10 HLA-DQB2 MCHR2 OR4Q3 P2RY13 GPR87 HTR3C OR4D11 TSHR GRIN1 GRM7 RGR ADGRG6 OR12D3 OR51S1 FCER2 OR56B1 LMBR1L OR4K1 SCN7A FSHR OR2Y1 ADGRF5 IL5RA | 5.22e-06 | 1353 | 173 | 29 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | ADGRG5 XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR GRM7 RGR ADGRG6 OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 ADGRF5 | 8.48e-06 | 884 | 173 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA2D1 GRIN1 CALHM3 GRM7 CLCN7 TMEM266 KCNQ2 CACNA1H CACNA1G | 3.34e-05 | 184 | 173 | 9 | GO:0022832 |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.46e-05 | 196 | 173 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC35E2B SLC5A5 SLC22A9 SLC8B1 CLCN7 SLC20A2 SLC16A14 SLC5A6 SLC22A3 SLC35A2 SLC28A1 | 5.67e-05 | 296 | 173 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.45e-05 | 49 | 173 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.01e-05 | 26 | 173 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | protein xylosyltransferase activity | 7.46e-05 | 2 | 173 | 2 | GO:0030158 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.92e-04 | 182 | 173 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.17e-04 | 14 | 173 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | biotin transmembrane transporter activity | 2.23e-04 | 3 | 173 | 2 | GO:0015225 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 2.23e-04 | 3 | 173 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.63e-04 | 102 | 173 | 6 | GO:0043178 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.30e-04 | 73 | 173 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 4.71e-04 | 42 | 173 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.69e-04 | 46 | 173 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 6.94e-04 | 81 | 173 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | iodide transmembrane transporter activity | 7.34e-04 | 5 | 173 | 2 | GO:0015111 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 7.34e-04 | 5 | 173 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 7.39e-04 | 171 | 173 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 9.96e-04 | 23 | 173 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.07e-03 | 52 | 173 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.71e-03 | 59 | 173 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.93e-03 | 61 | 173 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | symporter activity | 1.98e-03 | 150 | 173 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.12e-03 | 152 | 173 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 2.58e-03 | 9 | 173 | 2 | GO:0015186 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.61e-03 | 109 | 173 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.14e-03 | 34 | 173 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.20e-03 | 70 | 173 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | sterol binding | 3.37e-03 | 71 | 173 | 4 | GO:0032934 | |
| GeneOntologyMolecularFunction | amino acid binding | 3.72e-03 | 73 | 173 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.80e-03 | 119 | 173 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | UDP-xylosyltransferase activity | 3.90e-03 | 11 | 173 | 2 | GO:0035252 | |
| GeneOntologyMolecularFunction | xylosyltransferase activity | 3.90e-03 | 11 | 173 | 2 | GO:0042285 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2AK2 OR1B1 OR4D10 OR4Q3 OR4D11 OR12D3 OR51S1 OR56B1 OR4K1 OR2Y1 | 4.45e-03 | 431 | 173 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 4.65e-03 | 12 | 173 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 4.65e-03 | 12 | 173 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 4.65e-03 | 12 | 173 | 2 | GO:0019534 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYBB XCR1 CACNA2D1 RELN TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC22A9 ATP1B4 SLC8B1 CLCA1 THY1 CLCN7 TRPM3 SLC20A2 SLC5A6 SLC22A3 SCN7A SCN9A OTOP1 TMEM266 KCNQ2 CACNA1H CACNA1G ABCC2 | 1.40e-07 | 1374 | 174 | 32 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYBB XCR1 CACNA2D1 RELN TRPC4 TRPC5 HTR3C TMC4 GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC8B1 CLCA1 THY1 CLCN7 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 2.11e-07 | 1115 | 174 | 28 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | XCR1 CACNA2D1 TRPC4 TRPC5 HTR3C GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 CLCA1 THY1 CLCN7 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 4.33e-07 | 1017 | 174 | 26 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | XCR1 CACNA2D1 TRPC4 TRPC5 HTR3C GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 THY1 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 9.20e-07 | 922 | 174 | 24 | GO:0098662 |
| GeneOntologyBiologicalProcess | organic anion transport | PSG2 SLC38A9 TRPC4 CEACAM7 CALHM3 GRM7 SLC22A9 SLC16A14 SLC5A6 SLC22A3 SLC35A2 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 7.98e-06 | 515 | 174 | 16 | GO:0015711 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | PSG2 SLC38A9 TRPC4 CEACAM7 GRM7 SLC22A9 SLC16A14 SLC5A6 SLC22A3 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 1.05e-05 | 410 | 174 | 14 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | PSG2 SLC38A9 TRPC4 CEACAM7 GRM7 SLC22A9 SLC16A14 SLC5A6 SLC22A3 ABCG2 ABCD1 ABCC2 SLC51A SLC38A6 | 1.11e-05 | 412 | 174 | 14 | GO:0015849 |
| GeneOntologyBiologicalProcess | metal ion transport | XCR1 CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 CLCA1 THY1 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G ABCC2 | 1.22e-05 | 1000 | 174 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | PSG2 CEACAM7 SLC22A9 SLC16A14 SLC5A6 SLC22A3 ABCG2 ABCD1 ABCC2 SLC51A | 1.38e-05 | 213 | 174 | 10 | GO:0015718 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | XCR1 CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 SLC8B1 THY1 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 1.51e-05 | 942 | 174 | 22 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | XCR1 CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 SLC40A1 ITPR2 SLC5A5 SLC41A2 ATP1B4 SLC8B1 CLCA1 THY1 TRPM3 SLC20A2 SLC5A6 SCN7A SCN9A OTOP1 KCNQ2 CACNA1H CACNA1G ABCC2 | 4.15e-05 | 1157 | 174 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | long-term memory | 5.15e-05 | 48 | 174 | 5 | GO:0007616 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC5A5 SLC8B1 SLC20A2 SLC5A6 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 7.06e-05 | 208 | 174 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC5A5 ATP1B4 SLC8B1 SLC20A2 SLC5A6 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 1.19e-04 | 275 | 174 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | XCR1 CACNA2D1 TRPC4 TRPC5 GRIN1 CALHM3 ITPR2 SLC8B1 THY1 TRPM3 CACNA1H CACNA1G | 1.29e-04 | 392 | 174 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | iodide transmembrane transport | 2.11e-04 | 3 | 174 | 2 | GO:1904200 | |
| GeneOntologyBiologicalProcess | cellular response to glycoprotein | 2.11e-04 | 3 | 174 | 2 | GO:1904588 | |
| GeneOntologyBiologicalProcess | biotin transport | 2.11e-04 | 3 | 174 | 2 | GO:0015878 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.33e-04 | 36 | 174 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADGRG5 XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR GRM7 RGR ADCY8 ADGRG6 OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 SYP ADGRF5 C5 | 2.85e-04 | 1395 | 174 | 25 | GO:0007186 |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.96e-04 | 107 | 174 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 3.05e-04 | 16 | 174 | 3 | GO:0098976 | |
| GeneOntologyCellularComponent | cell surface | XCR1 ANPEP PSG2 HLA-DQB2 TRPC4 CEACAM7 TSHR GRIN1 GRM7 AQP4 ADGRG6 THY1 CEACAM21 CD9 FCER2 CLU CD80 FSHR KCNQ2 ADGRF5 ABCG2 STRC ABCC2 IL5RA CD276 | 1.04e-05 | 1111 | 180 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.16e-05 | 17 | 180 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | PSG2 TRPC4 CEACAM7 TSHR CALHM3 AQP4 SLC40A1 ADCY8 SLC22A9 SLC5A6 SLC22A3 SLC51A | 2.26e-05 | 320 | 180 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CYBB CACNA2D1 CATSPERD TRPC4 TRPC5 HTR3C GRIN1 CLCN7 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 2.55e-05 | 378 | 180 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA2D1 CATSPERD TRPC4 TRPC5 HTR3C SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 3.84e-05 | 235 | 180 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | calcium channel complex | 3.96e-05 | 73 | 180 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | basal plasma membrane | PSG2 TRPC4 CEACAM7 TSHR CALHM3 AQP4 SLC40A1 ADCY8 SLC22A9 SLC5A6 SLC22A3 SLC51A | 6.02e-05 | 354 | 180 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | brush border membrane | 8.17e-05 | 83 | 180 | 6 | GO:0031526 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.07e-04 | 29 | 180 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | basal part of cell | PSG2 TRPC4 CEACAM7 TSHR CALHM3 AQP4 SLC40A1 ADCY8 SLC22A9 SLC5A6 SLC22A3 SLC51A | 1.12e-04 | 378 | 180 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CYBB CACNA2D1 CATSPERD PSG2 HLA-DQB2 CEACAM7 HTR3C GRIN1 TICAM2 ATP1B4 NOX1 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G C5 TRAV13-1 | 1.56e-04 | 785 | 180 | 18 | GO:0098797 |
| GeneOntologyCellularComponent | external side of plasma membrane | XCR1 ANPEP PSG2 HLA-DQB2 CEACAM7 AQP4 THY1 CEACAM21 CD9 FCER2 CD80 ABCG2 IL5RA CD276 | 1.69e-04 | 519 | 180 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CYBB CACNA2D1 CATSPERD TRPC4 TRPC5 HTR3C GRIN1 ATP1B4 CLCN7 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 1.83e-04 | 523 | 180 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CYBB CACNA2D1 CATSPERD TRPC4 TRPC5 HTR3C GRIN1 ATP1B4 CLCN7 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G | 3.05e-04 | 550 | 180 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 6.54e-04 | 46 | 180 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | apical plasma membrane | PSG2 CEACAM7 ADCY8 THY1 CEACAM21 CD9 SLC20A2 SLC5A6 SLC22A3 SLC28A1 ABCG2 ABCC2 | 1.09e-03 | 487 | 180 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | membrane protein complex | CYBB CACNA2D1 CATSPERD PSG2 SLC38A9 HLA-DQB2 TRPC4 TRPC5 CEACAM7 HTR3C GRIN1 TICAM2 STT3B ATP1B4 NOX1 CLCN7 AP1B1 SCN7A SCN9A INSIG2 KCNQ2 CACNA1H CACNA1G C5 TRAV13-1 | 1.10e-03 | 1498 | 180 | 25 | GO:0098796 |
| GeneOntologyCellularComponent | cell projection membrane | ANPEP PSG2 CEACAM7 GRIN1 AQP4 THY1 SLC20A2 SLC5A6 SLC28A1 ABCG2 ABCC2 | 1.32e-03 | 431 | 180 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.41e-03 | 141 | 180 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | apical part of cell | PSG2 CEACAM7 ADCY8 THY1 CEACAM21 CD9 SLC20A2 SLC5A6 SLC22A3 SLC28A1 ADGRF5 ABCG2 ABCC2 | 1.91e-03 | 592 | 180 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 1.95e-03 | 29 | 180 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | brush border | 2.06e-03 | 152 | 180 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.35e-03 | 107 | 180 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | spherical high-density lipoprotein particle | 2.55e-03 | 9 | 180 | 2 | GO:0034366 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.83e-03 | 277 | 180 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.17e-03 | 10 | 180 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | nuclear pore outer ring | 3.17e-03 | 10 | 180 | 2 | GO:0031080 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.26e-03 | 223 | 180 | 7 | GO:0098862 | |
| MousePheno | abnormal single cell response | 1.80e-05 | 35 | 132 | 5 | MP:0003463 | |
| MousePheno | abnormal glial cell morphology | CTSF GPR17 MARVELD1 FKRP LYST ADGRG6 CLCN7 SLC20A2 FSHR ATXN3 CACNA1G ABCD1 FOXJ1 | 2.30e-05 | 345 | 132 | 13 | MP:0003634 |
| MousePheno | abnormal CNS glial cell morphology | GPR17 MARVELD1 FKRP LYST CLCN7 SLC20A2 FSHR ATXN3 CACNA1G ABCD1 FOXJ1 | 5.34e-05 | 272 | 132 | 11 | MP:0000952 |
| Domain | Ion_trans_dom | TRPC4 TRPC5 ITPR2 TRPM3 SCN7A SCN9A TMEM266 KCNQ2 CACNA1H CACNA1G | 7.21e-08 | 114 | 166 | 10 | IPR005821 |
| Domain | Ion_trans | TRPC4 TRPC5 ITPR2 TRPM3 SCN7A SCN9A TMEM266 KCNQ2 CACNA1H CACNA1G | 7.21e-08 | 114 | 166 | 10 | PF00520 |
| Domain | GPCR_Rhodpsn_7TM | XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR RGR OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 | 2.99e-05 | 670 | 166 | 18 | IPR017452 |
| Domain | 7tm_1 | XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR RGR OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 | 3.43e-05 | 677 | 166 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR RGR OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 | 4.00e-05 | 685 | 166 | 18 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR RGR OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 | 4.47e-05 | 691 | 166 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | XCR1 OR2AK2 GPR17 OR1B1 OR4D10 MCHR2 OR4Q3 P2RY13 GPR87 OR4D11 TSHR RGR OR12D3 OR51S1 OR56B1 OR4K1 FSHR OR2Y1 | 4.56e-05 | 692 | 166 | 18 | IPR000276 |
| Domain | ABC_tran | 6.56e-05 | 48 | 166 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 6.56e-05 | 48 | 166 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 7.26e-05 | 49 | 166 | 5 | PS00211 | |
| Domain | XylT | 7.85e-05 | 2 | 166 | 2 | IPR024448 | |
| Domain | Xylo_C | 7.85e-05 | 2 | 166 | 2 | PF12529 | |
| Domain | ABC_transporter-like | 8.01e-05 | 50 | 166 | 5 | IPR003439 | |
| Domain | Channel_four-helix_dom | 1.51e-04 | 57 | 166 | 5 | IPR027359 | |
| Domain | - | 1.51e-04 | 57 | 166 | 5 | 1.20.120.350 | |
| Domain | VDCC_T_a1 | 2.34e-04 | 3 | 166 | 2 | IPR005445 | |
| Domain | P2Y13_rcpt | 2.34e-04 | 3 | 166 | 2 | IPR008109 | |
| Domain | ig | 3.04e-04 | 190 | 166 | 8 | PF00047 | |
| Domain | Immunoglobulin | 3.04e-04 | 190 | 166 | 8 | IPR013151 | |
| Domain | AAA | 3.06e-04 | 144 | 166 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 3.06e-04 | 144 | 166 | 7 | IPR003593 | |
| Domain | Cyt_b245_heavy_chain | 4.66e-04 | 4 | 166 | 2 | IPR000778 | |
| Domain | TRP_2 | 1.15e-03 | 6 | 166 | 2 | PF08344 | |
| Domain | L6_membrane | 1.15e-03 | 6 | 166 | 2 | IPR008661 | |
| Domain | Gphrmn_rcpt_fam | 1.15e-03 | 6 | 166 | 2 | IPR002131 | |
| Domain | TRP_dom | 1.15e-03 | 6 | 166 | 2 | IPR013555 | |
| Domain | L6_membrane | 1.15e-03 | 6 | 166 | 2 | PF05805 | |
| Domain | MFS_dom | 1.27e-03 | 134 | 166 | 6 | IPR020846 | |
| Domain | Ig_I-set | 1.57e-03 | 190 | 166 | 7 | IPR013098 | |
| Domain | I-set | 1.57e-03 | 190 | 166 | 7 | PF07679 | |
| Domain | TRPC_channel | 1.60e-03 | 7 | 166 | 2 | IPR002153 | |
| Domain | NAD_binding_6 | 1.60e-03 | 7 | 166 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.60e-03 | 7 | 166 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.60e-03 | 7 | 166 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.60e-03 | 7 | 166 | 2 | IPR013121 | |
| Domain | Ig_V-set | 2.05e-03 | 199 | 166 | 7 | IPR013106 | |
| Domain | Glyco_trans_14 | 2.12e-03 | 8 | 166 | 2 | IPR003406 | |
| Domain | Na/solute_symporter_CS | 2.12e-03 | 8 | 166 | 2 | IPR018212 | |
| Domain | Branch | 2.12e-03 | 8 | 166 | 2 | PF02485 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LMF1 TRPC4 TRPC5 AQP4 SLC40A1 ADCY8 SLC5A5 SLC41A2 SLC8B1 CLCA1 CLCN7 ABCA6 TRPM3 SLC20A2 SLC5A6 SLC22A3 SLC35A2 SLC28A1 ABCG2 ABCD1 ABCC2 UNC79 | 6.19e-07 | 736 | 127 | 22 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LMF1 TRPC4 TRPC5 AQP4 SLC40A1 SLC5A5 SLC41A2 SLC8B1 CLCA1 CLCN7 ABCA6 TRPM3 SLC20A2 SLC5A6 SLC22A3 SLC35A2 SLC28A1 ABCD1 ABCC2 UNC79 | 2.81e-06 | 681 | 127 | 20 | MM14985 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.06e-05 | 99 | 127 | 7 | M27474 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | NUP85 NUP43 SLC40A1 NUP205 SLC5A5 SLC20A2 SLC35A2 ABCD1 ABCC2 | 3.15e-05 | 177 | 127 | 9 | M27476 |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.49e-05 | 44 | 127 | 5 | M11911 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.68e-04 | 99 | 127 | 6 | MM14910 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 3.00e-04 | 15 | 127 | 3 | M22002 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC40A1 SLC5A5 SLC41A2 SLC8B1 SLC20A2 SLC5A6 SLC22A3 SLC35A2 SLC28A1 | 3.02e-04 | 238 | 127 | 9 | MM15076 |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.88e-04 | 106 | 127 | 6 | M27200 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC40A1 SLC5A5 SLC41A2 SLC8B1 SLC20A2 SLC5A6 SLC22A3 SLC35A2 SLC28A1 | 4.20e-04 | 249 | 127 | 9 | M5988 |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 1.51e-07 | 77 | 179 | 7 | 16944957 | |
| Pubmed | NMDA receptor-dependent synaptic activation of TRPC channels in olfactory bulb granule cells. | 5.34e-07 | 4 | 179 | 3 | 22539836 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.68e-07 | 139 | 179 | 8 | 16985003 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 10982830 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 9395467 | ||
| Pubmed | 1.53e-06 | 17 | 179 | 4 | 16595723 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 8973644 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | UBR2 CACNA2D1 ANPEP FKRP TMTC2 ST3GAL2 STT3B ITPR2 XYLT2 THY1 MEGF8 CLU SLC5A6 SLC22A3 SLC35A2 SEL1L3 RFT1 TOR3A FKBP14 CD276 | 4.27e-06 | 1201 | 179 | 20 | 35696571 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 MARVELD1 NUP85 HECTD4 SLC35E2B BIRC6 LYST ITPR2 FZR1 SLC8B1 CLCN7 MEGF8 SLC35A2 SEC16A KCNQ2 PCNX1 CACNA1H ABCD1 CD276 | 4.78e-06 | 1105 | 179 | 19 | 35748872 |
| Pubmed | 7.37e-06 | 8 | 179 | 3 | 12482980 | ||
| Pubmed | 7.37e-06 | 8 | 179 | 3 | 21389258 | ||
| Pubmed | 8.13e-06 | 257 | 179 | 9 | 16335952 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2AK2 OR1B1 OR4D10 OR4Q3 OR4D11 OR12D3 OR51S1 OR56B1 OR4K1 OR2Y1 | 1.17e-05 | 340 | 179 | 10 | 11875048 |
| Pubmed | OR2AK2 OR1B1 OR4D10 OR4Q3 OR4D11 OR12D3 OR51S1 OR56B1 OR4K1 OR2Y1 | 1.17e-05 | 340 | 179 | 10 | 11802173 | |
| Pubmed | OR2AK2 OR1B1 OR4D10 OR4Q3 OR4D11 OR12D3 OR51S1 OR56B1 OR4K1 OR2Y1 | 1.26e-05 | 343 | 179 | 10 | 32295537 | |
| Pubmed | OR2AK2 OR1B1 OR4D10 OR4Q3 OR4D11 OR12D3 OR51S1 OR56B1 OR4K1 OR2Y1 | 1.36e-05 | 346 | 179 | 10 | 14611657 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 1.57e-05 | 10 | 179 | 3 | 18989690 | |
| Pubmed | 2.15e-05 | 11 | 179 | 3 | 28598330 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23064009 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 14988077 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21622683 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 32826330 | ||
| Pubmed | NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice. | 2.63e-05 | 2 | 179 | 2 | 24379900 | |
| Pubmed | Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis. | 2.63e-05 | 2 | 179 | 2 | 10383739 | |
| Pubmed | Expression of xylosyltransferases I and II and their role in the pathogenesis of arthrofibrosis. | 2.63e-05 | 2 | 179 | 2 | 31973761 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18763033 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11099377 | ||
| Pubmed | Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. | 2.63e-05 | 2 | 179 | 2 | 24353283 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16877542 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 20685979 | ||
| Pubmed | Redox modifier genes in amyotrophic lateral sclerosis in mice. | 2.63e-05 | 2 | 179 | 2 | 17853944 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 27212019 | ||
| Pubmed | Xylosyltransferase gene variants and their role in essential hypertension. | 2.63e-05 | 2 | 179 | 2 | 19197251 | |
| Pubmed | Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases. | 2.63e-05 | 2 | 179 | 2 | 22412195 | |
| Pubmed | Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis. | 2.63e-05 | 2 | 179 | 2 | 26988594 | |
| Pubmed | VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity. | 2.63e-05 | 2 | 179 | 2 | 37820403 | |
| Pubmed | The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation. | 2.63e-05 | 2 | 179 | 2 | 24494191 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19541926 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23436820 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 33609631 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31042060 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25340405 | ||
| Pubmed | Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma. | 2.63e-05 | 2 | 179 | 2 | 31874997 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22457348 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17189265 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17189266 | ||
| Pubmed | mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer. | 2.63e-05 | 2 | 179 | 2 | 21732348 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23677990 | ||
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 2.63e-05 | 2 | 179 | 2 | 32033274 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19014925 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 29873816 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17624425 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 29921713 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25460197 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16164625 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34899056 | ||
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 2.63e-05 | 2 | 179 | 2 | 17593972 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31677793 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 28314819 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25066694 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22781452 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15812828 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21989446 | ||
| Pubmed | Activation of NADPH oxidases leads to DNA damage in esophageal cells. | 2.63e-05 | 2 | 179 | 2 | 28855537 | |
| Pubmed | Metabolism, Transport and Drug-Drug Interactions of Silymarin. | 2.63e-05 | 2 | 179 | 2 | 31615114 | |
| Pubmed | NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. | 2.63e-05 | 2 | 179 | 2 | 19661248 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21638318 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 33301718 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 26317356 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16569644 | ||
| Pubmed | Localization of human thyrotropin receptor gene to chromosome region 14q3 by in situ hybridization. | 2.63e-05 | 2 | 179 | 2 | 2249482 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 32965647 | ||
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 2.63e-05 | 2 | 179 | 2 | 9687496 | |
| Pubmed | Endothelial NADPH oxidases: which NOX to target in vascular disease? | 2.63e-05 | 2 | 179 | 2 | 25066192 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 28365776 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 38053850 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22469755 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17015737 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25793771 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34087576 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23836548 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21079360 | ||
| Pubmed | NADPH Oxidases Are Essential for Macrophage Differentiation. | 2.63e-05 | 2 | 179 | 2 | 27489105 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22886848 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34039739 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 29082441 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19389916 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17003309 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22574369 | ||
| Pubmed | Xylosyltransferase activity in seminal plasma of infertile men. | 2.63e-05 | 2 | 179 | 2 | 11814476 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23381786 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17938324 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 2.63e-05 | 2 | 179 | 2 | 21438841 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11087729 | ||
| Pubmed | TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. | 2.63e-05 | 2 | 179 | 2 | 30038709 | |
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 2.63e-05 | 2 | 179 | 2 | 22808078 | |
| Pubmed | Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene. | 3.69e-05 | 13 | 179 | 3 | 8976376 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.37e-05 | 38 | 179 | 4 | 30786075 | |
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 7.15e-05 | 16 | 179 | 3 | 11284729 | |
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 7.15e-05 | 16 | 179 | 3 | 19679677 | |
| Interaction | FUT3 interactions | 2.21e-06 | 27 | 162 | 5 | int:FUT3 | |
| Interaction | TMEM179B interactions | 8.75e-06 | 91 | 162 | 7 | int:TMEM179B | |
| Cytoband | 22q11.2 | 1.16e-04 | 120 | 180 | 5 | 22q11.2 | |
| Cytoband | Xp11.23-p11.22 | 3.17e-04 | 7 | 180 | 2 | Xp11.23-p11.22 | |
| GeneFamily | Solute carriers | SLC38A9 SLC35E2B SLC40A1 SLC5A5 SLC41A2 SLC22A9 SLC8B1 SLC20A2 SLC16A14 SLC5A6 SLC22A3 SLC35A2 SLC49A4 SLC28A1 SLC51A SLC38A6 | 1.59e-08 | 395 | 126 | 16 | 752 |
| GeneFamily | Glycoprotein hormone receptors | 1.44e-04 | 3 | 126 | 2 | 199 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 3.95e-04 | 89 | 126 | 5 | 353 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.64e-04 | 26 | 126 | 3 | 253 | |
| GeneFamily | Transient receptor potential cation channels | 9.53e-04 | 28 | 126 | 3 | 249 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 9.89e-04 | 7 | 126 | 2 | 917 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 1.31e-03 | 8 | 126 | 2 | 441 | |
| GeneFamily | Nucleoporins | 1.41e-03 | 32 | 126 | 3 | 1051 | |
| GeneFamily | ATP binding cassette subfamily A | 4.15e-03 | 14 | 126 | 2 | 805 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN | CYBB ST3GAL2 CYFIP1 CLCA1 CEACAM21 AP1B1 CD80 MED12L ABCC2 RNF26 | 8.30e-07 | 200 | 171 | 10 | M6952 |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 ANPEP GPR87 TMC4 SLC41A2 CLCA1 CLU HPR SLC22A3 SEL1L3 C5 SDR16C5 | 2.70e-11 | 198 | 177 | 12 | 6712216c5a7fd86b68fd45b0ff7794975f19774e |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 CLU HPR SLC22A3 SDR16C5 | 4.68e-10 | 198 | 177 | 11 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 CLU HPR SLC22A3 SDR16C5 | 4.68e-10 | 198 | 177 | 11 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 HPR SEL1L3 SDR16C5 | 7.37e-09 | 198 | 177 | 10 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 HPR SEL1L3 SDR16C5 | 7.37e-09 | 198 | 177 | 10 | e035380578c01b0243bfef29ca9b50cc17cce771 |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 ANPEP GPR87 TMC4 DNAH7 CLCA1 CLU HPR SEL1L3 SDR16C5 | 7.73e-09 | 199 | 177 | 10 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 ANPEP GPR87 CLCA1 CLU HPR SLC22A3 SEL1L3 C5 SDR16C5 | 7.73e-09 | 199 | 177 | 10 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 ANPEP GPR87 TMC4 DNAH7 CLCA1 CLU HPR SEL1L3 SDR16C5 | 7.73e-09 | 199 | 177 | 10 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 CLU HPR SDR16C5 | 8.11e-09 | 200 | 177 | 10 | cf191104484bfb2b9f87de416b9453135f8833c1 |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 CLU HPR SDR16C5 | 8.11e-09 | 200 | 177 | 10 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 HPR SDR16C5 IL5RA | 8.11e-09 | 200 | 177 | 10 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 DNAH3 ANPEP GPR87 DNAH7 CFAP65 CLCA1 HPR SDR16C5 IL5RA | 8.11e-09 | 200 | 177 | 10 | da12821e8a0657869ca0f75d351cce2d7605a505 |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ST6GALNAC1 GPR87 TMC4 SLC41A2 CLCA1 CLU SLC22A3 SEL1L3 SDR16C5 | 2.29e-08 | 166 | 177 | 9 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ST6GALNAC1 GPR87 TMC4 SLC41A2 CLCA1 CLU SLC22A3 SEL1L3 SDR16C5 | 2.29e-08 | 166 | 177 | 9 | 9628522e7af8f8edca733588a364ab2454ac5ca5 |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 8.02e-08 | 192 | 177 | 9 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.99e-08 | 197 | 177 | 9 | 075044c17f1c52008cd3c292c15cbf485b50411e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ST6GALNAC1 ANPEP GPR87 CFAP65 CLCA1 HPR SLC22A3 SEL1L3 SDR16C5 | 1.09e-07 | 199 | 177 | 9 | 8649c2380285a668782d75eb076ce548eed0911d |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 158 | 177 | 8 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-07 | 168 | 177 | 8 | af82e07d1eec51fc6530155f37addbce6221885d | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 3.99e-07 | 169 | 177 | 8 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-07 | 169 | 177 | 8 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-07 | 169 | 177 | 8 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 3.99e-07 | 169 | 177 | 8 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 4.56e-07 | 172 | 177 | 8 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 4.56e-07 | 172 | 177 | 8 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-07 | 174 | 177 | 8 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.16e-07 | 179 | 177 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-06 | 195 | 177 | 8 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.17e-06 | 195 | 177 | 8 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.17e-06 | 195 | 177 | 8 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.22e-06 | 196 | 177 | 8 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.27e-06 | 197 | 177 | 8 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-06 | 197 | 177 | 8 | 9936dc179aa0cf8aadf77946b26c09ad33848dc2 | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-06 | 197 | 177 | 8 | 9e0850b6bb952757c74ba816e30006199e562bfa | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 197 | 177 | 8 | 5474774c2ff7a13ec1a020e2fef4efa72e34727b | |
| ToppCell | Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-06 | 197 | 177 | 8 | 365654a344bfdd2533cfcbed05063427b40f47b9 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-Plasma_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.27e-06 | 197 | 177 | 8 | 3259d7ce3e6dde1beda8b534bdf7ff5c7fc1a46c | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 177 | 8 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 199 | 177 | 8 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.37e-06 | 199 | 177 | 8 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | df90b67490cd649de3e3a713762ffbc34a698899 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.42e-06 | 200 | 177 | 8 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 3.79e-06 | 161 | 177 | 7 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-06 | 164 | 177 | 7 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 4.46e-06 | 165 | 177 | 7 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.64e-06 | 166 | 177 | 7 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.64e-06 | 166 | 177 | 7 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 166 | 177 | 7 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-06 | 168 | 177 | 7 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-06 | 168 | 177 | 7 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 168 | 177 | 7 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 168 | 177 | 7 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|RA / Chamber and Cluster_Paper | 5.20e-06 | 110 | 177 | 6 | af7095c6e1501a4440be39b5c16d4872dd6d66e5 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 171 | 177 | 7 | fea6ef6bbfebea2dd0f0360c7db7a5e858f15958 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 171 | 177 | 7 | f15594fd4d709920733de9376a391dedc62b65de | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-06 | 173 | 177 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 6.09e-06 | 173 | 177 | 7 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 174 | 177 | 7 | b4483d7d9f22f09ed7fa0b72305434a47ccaade0 | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.72e-06 | 115 | 177 | 6 | 0a37816898eaa18ae49d4d936e1a760f089e0ceb | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.33e-06 | 178 | 177 | 7 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.33e-06 | 178 | 177 | 7 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 7.61e-06 | 179 | 177 | 7 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-06 | 179 | 177 | 7 | ae9d90a4eac2cfa545a764df84914c5801544278 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 179 | 177 | 7 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-06 | 180 | 177 | 7 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-06 | 180 | 177 | 7 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 180 | 177 | 7 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-06 | 181 | 177 | 7 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-06 | 181 | 177 | 7 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-06 | 181 | 177 | 7 | 4a225d9a6d113396c6b1d0a839bb4ca9c339a260 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 8.48e-06 | 182 | 177 | 7 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.10e-06 | 184 | 177 | 7 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.10e-06 | 184 | 177 | 7 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.10e-06 | 184 | 177 | 7 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.10e-06 | 184 | 177 | 7 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.43e-06 | 185 | 177 | 7 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-06 | 185 | 177 | 7 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.43e-06 | 185 | 177 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-06 | 185 | 177 | 7 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-06 | 186 | 177 | 7 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 187 | 177 | 7 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 187 | 177 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-05 | 189 | 177 | 7 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|World / Lineage and Cell class | 1.08e-05 | 189 | 177 | 7 | 51ff31c9cf5eff98ad01c0455dc4ae4908713575 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 191 | 177 | 7 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-05 | 191 | 177 | 7 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.16e-05 | 191 | 177 | 7 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 191 | 177 | 7 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 191 | 177 | 7 | 17746a32f723c078aba1f7e320b0e3f1ab8bf5c6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-05 | 191 | 177 | 7 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.16e-05 | 191 | 177 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 191 | 177 | 7 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 191 | 177 | 7 | c7b95a5f9185d533c08754ce2e4ce91533eb612e | |
| ToppCell | cellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 191 | 177 | 7 | c2c450df810f83163987cd0f7ed9b50025cd3de1 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 192 | 177 | 7 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-05 | 192 | 177 | 7 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 192 | 177 | 7 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| Computational | Porins / transporters. | 7.10e-05 | 211 | 91 | 9 | MODULE_63 | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.56e-06 | 195 | 173 | 10 | 4300_UP | |
| Drug | Ro 31-8959 | 3.59e-06 | 84 | 173 | 7 | CID000060787 | |
| Drug | verapamil | CACNA2D1 ABCA13 BIRC6 ADCY8 CD9 ABCA6 SLC22A3 SCN7A SCN9A KCNQ2 CACNA1H CACNA1G ABCG2 ABCD1 ABCC2 | 5.40e-06 | 490 | 173 | 15 | CID000002520 |
| Drug | NSC 612567 | 8.48e-06 | 6 | 173 | 3 | CID000163858 | |
| Drug | 6-OH-BDE-47 | 1.48e-05 | 7 | 173 | 3 | ctd:C580599 | |
| Drug | AC1L1HWS | 1.74e-05 | 21 | 173 | 4 | CID000004326 | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.99e-05 | 196 | 173 | 9 | 2795_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.15e-05 | 198 | 173 | 9 | 3523_UP | |
| Drug | metazachlor | 2.35e-05 | 8 | 173 | 3 | CID000049384 | |
| Drug | NSC 613060 | 2.35e-05 | 8 | 173 | 3 | CID000163987 | |
| Drug | OC144-093 | 2.35e-05 | 8 | 173 | 3 | CID006450807 | |
| Drug | GF120918 | 3.04e-05 | 24 | 173 | 4 | CID000119373 | |
| Drug | IAARh123 | 3.50e-05 | 9 | 173 | 3 | CID000656577 | |
| Drug | Landel | 3.50e-05 | 9 | 173 | 3 | CID000163838 | |
| Disease | Secondary Biliary Cholangitis | 3.28e-06 | 42 | 161 | 5 | C0238065 | |
| Disease | Biliary cirrhosis | 3.28e-06 | 42 | 161 | 5 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 3.28e-06 | 42 | 161 | 5 | C4551595 | |
| Disease | Primary biliary cirrhosis | 5.79e-06 | 47 | 161 | 5 | C0008312 | |
| Disease | uric acid measurement | DNAH3 HLA-DQB2 HECTD4 ETV5 TSHR BIRC6 GLMN ABCA6 SLC20A2 SLC22A3 TMEM266 ABCG2 RFT1 | 3.25e-05 | 610 | 161 | 13 | EFO_0004761 |
| Disease | Pseudoxanthoma Elasticum, Incomplete | 8.84e-05 | 3 | 161 | 2 | C1867450 | |
| Disease | Pseudoxanthoma elasticum | 8.84e-05 | 3 | 161 | 2 | cv:C0033847 | |
| Disease | Autosomal recessive inherited pseudoxanthoma elasticum | 8.84e-05 | 3 | 161 | 2 | cv:C1275116 | |
| Disease | PSEUDOXANTHOMA ELASTICUM | 8.84e-05 | 3 | 161 | 2 | 264800 | |
| Disease | Gronblad-Strandberg Syndrome | 8.84e-05 | 3 | 161 | 2 | C0376359 | |
| Disease | orotidine measurement | 1.76e-04 | 4 | 161 | 2 | EFO_0800630 | |
| Disease | Paraparesis, Spastic | 1.76e-04 | 4 | 161 | 2 | C0037771 | |
| Disease | Pseudoxanthoma Elasticum | 1.76e-04 | 4 | 161 | 2 | C0033847 | |
| Disease | Intellectual Disability | ZC3H14 GRIN1 STT3B PTCHD1 AP1B1 TRPM3 SLC5A6 SLC35A2 MED12L CACNA1G | 1.83e-04 | 447 | 161 | 10 | C3714756 |
| Disease | Seizures | 2.03e-04 | 218 | 161 | 7 | C0036572 | |
| Disease | Brain Infarction, Posterior Circulation | 2.93e-04 | 5 | 161 | 2 | C0751953 | |
| Disease | Anterior Circulation Brain Infarction | 2.93e-04 | 5 | 161 | 2 | C0751952 | |
| Disease | Brain Infarction | 2.93e-04 | 5 | 161 | 2 | C0751955 | |
| Disease | Venous Infarction, Brain | 2.93e-04 | 5 | 161 | 2 | C0751954 | |
| Disease | Lupus Erythematosus, Discoid | 2.93e-04 | 5 | 161 | 2 | C0024138 | |
| Disease | Anterior Cerebral Circulation Infarction | 2.93e-04 | 5 | 161 | 2 | C0393953 | |
| Disease | Failure to Thrive | 4.37e-04 | 6 | 161 | 2 | C0015544 | |
| Disease | taurocholenate sulfate measurement | 4.37e-04 | 6 | 161 | 2 | EFO_0800277 | |
| Disease | Abnormal corpus callosum morphology | 4.37e-04 | 6 | 161 | 2 | C1842581 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 4.72e-04 | 28 | 161 | 3 | DOID:784 (biomarker_via_orthology) | |
| Disease | Autistic Disorder | 6.00e-04 | 261 | 161 | 7 | C0004352 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | retinal disease (biomarker_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:5679 (biomarker_via_orthology) | |
| Disease | pseudoxanthoma elasticum (is_implicated_in) | 1.04e-03 | 9 | 161 | 2 | DOID:2738 (is_implicated_in) | |
| Disease | Gastrointestinal Hemorrhage | 1.04e-03 | 9 | 161 | 2 | C0017181 | |
| Disease | tryptase beta-2 measurement | 1.04e-03 | 9 | 161 | 2 | EFO_0008306 | |
| Disease | Drug toxicity | 1.17e-03 | 84 | 161 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 1.17e-03 | 84 | 161 | 4 | C0041755 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.29e-03 | 10 | 161 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.29e-03 | 10 | 161 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | urate measurement | DNAH3 HLA-DQB2 HECTD4 BIRC6 STT3B MALRD1 DGAT2 SLC20A2 SLC22A3 SLC28A1 TMEM266 ABCG2 RFT1 | 1.30e-03 | 895 | 161 | 13 | EFO_0004531 |
| Disease | response to antihypertensive drug | 1.46e-03 | 41 | 161 | 3 | EFO_0005405 | |
| Disease | lipid measurement, lipoprotein measurement | 1.52e-03 | 90 | 161 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | fibroblast growth factor 23 measurement | 1.68e-03 | 43 | 161 | 3 | EFO_0009381 | |
| Disease | Colorectal Carcinoma | DNAH3 ABCA13 GPR87 HTR3C LRRC4 ADCY8 SLC22A9 CD9 ABCA6 ABCG2 ABCC2 | 1.70e-03 | 702 | 161 | 11 | C0009402 |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.71e-03 | 93 | 161 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.00e-03 | 97 | 161 | 4 | DOID:3083 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.15e-03 | 99 | 161 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | total lipids in small LDL | 2.17e-03 | 47 | 161 | 3 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 2.17e-03 | 47 | 161 | 3 | EFO_0022269 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.22e-03 | 13 | 161 | 2 | C3501611 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 2.22e-03 | 13 | 161 | 2 | EFO_0800474 | |
| Disease | status epilepticus (biomarker_via_orthology) | 2.23e-03 | 100 | 161 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.40e-03 | 102 | 161 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.58e-03 | 14 | 161 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Spastic Paraplegia, Hereditary | 2.58e-03 | 14 | 161 | 2 | C0037773 | |
| Disease | X-21470 measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0800817 | |
| Disease | Tourette syndrome | 2.59e-03 | 50 | 161 | 3 | EFO_0004895 | |
| Disease | phospholipids in medium VLDL measurement | 2.90e-03 | 52 | 161 | 3 | EFO_0022154 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.90e-03 | 52 | 161 | 3 | C1168401 | |
| Disease | brain edema (biomarker_via_orthology) | 2.97e-03 | 15 | 161 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Epilepsy | 3.05e-03 | 109 | 161 | 4 | C0014544 | |
| Disease | phospholipids in large LDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022174 | |
| Disease | nervous system disorder | 3.06e-03 | 53 | 161 | 3 | C0027765 | |
| Disease | cholesterol in small VLDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022228 | |
| Disease | Neuralgia, Supraorbital | 3.38e-03 | 16 | 161 | 2 | C0038870 | |
| Disease | Neuralgia | 3.38e-03 | 16 | 161 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 3.38e-03 | 16 | 161 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.38e-03 | 16 | 161 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.38e-03 | 16 | 161 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.38e-03 | 16 | 161 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 3.38e-03 | 16 | 161 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.38e-03 | 16 | 161 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.38e-03 | 16 | 161 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 3.38e-03 | 16 | 161 | 2 | C0042656 | |
| Disease | gout, hyperuricemia | 3.38e-03 | 16 | 161 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | Schizophrenia | ST6GALNAC1 RELN ABCA13 MCHR2 GRM7 AQP4 CFAP65 CYFIP1 CEACAM21 CLU SYP KCNQ2 | 3.42e-03 | 883 | 161 | 12 | C0036341 |
| Disease | high altitude adaptation | 3.81e-03 | 17 | 161 | 2 | EFO_0009105 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.87e-03 | 189 | 161 | 5 | EFO_0009932 | |
| Disease | phospholipids in LDL measurement | 3.95e-03 | 58 | 161 | 3 | EFO_0022294 | |
| Disease | phospholipids in small LDL measurement | 4.14e-03 | 59 | 161 | 3 | EFO_0022297 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 4.27e-03 | 18 | 161 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | phospholipids in small VLDL measurement | 4.34e-03 | 60 | 161 | 3 | EFO_0022146 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 4.61e-03 | 197 | 161 | 5 | EFO_0005680 | |
| Disease | smoking status measurement | MON2 FKRP TRPC4 MCHR2 HECTD4 GRM7 BIRC6 ADCY8 XYLT1 FZR1 MED12L CNTNAP4 UNC79 CD276 | 4.64e-03 | 1160 | 161 | 14 | EFO_0006527 |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.76e-03 | 19 | 161 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | diabetes mellitus (biomarker_via_orthology) | 4.76e-03 | 19 | 161 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | puberty onset measurement | 4.96e-03 | 125 | 161 | 4 | EFO_0005677 | |
| Disease | visceral adipose tissue measurement | 5.06e-03 | 481 | 161 | 8 | EFO_0004765 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 5.27e-03 | 20 | 161 | 2 | DOID:3328 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WAILAGLGTSLLQVI | 291 | P40145 | |
| LIFVLLSLGSTINWG | 46 | P55087 | |
| LNQASITSFLTVLAW | 2696 | Q9NR09 | |
| QRGILLLWFENSLLF | 251 | Q86XM0 | |
| LNLLFLLDGWITSFN | 911 | Q86SQ4 | |
| QGLLLTASLLTFWNA | 16 | Q3KPI0 | |
| QAIGWSVTLLLIIAA | 181 | Q86XJ0 | |
| ILALVGNTLALWLFI | 71 | Q13304 | |
| VLTNLVVFLLTLFWG | 326 | Q8N139 | |
| FSGLLVNLTTIASWL | 551 | Q9UNQ0 | |
| VTIISWLNLFLQVDA | 241 | O96020 | |
| GAVLKTLLLLSTQNW | 6 | Q9C0A0 | |
| WIFVQLASQGTVLLL | 4656 | Q86UQ4 | |
| LGVDAQLQLLTSFLW | 76 | Q8WXA8 | |
| LYQSLKLTNGIWVLA | 896 | Q10567 | |
| LFSTSGNEWVLLNLN | 611 | P15144 | |
| PGFSLAQLNLIWQLT | 56 | Q5ZPR3 | |
| FSLAQLNLIWQLTDT | 276 | Q5ZPR3 | |
| QGLLLTASLLTFWNL | 16 | Q14002 | |
| DNLLPSWAITLISVN | 241 | P33681 | |
| FLARTGQSWSLILLI | 101 | Q9UN42 | |
| ILTVNSIGQLKIWDF | 186 | Q8NFH3 | |
| ILGSQTALITTVWLN | 466 | Q09MP3 | |
| LALQFARLGSVLVLW | 56 | Q8N3Y7 | |
| QTLNLLWLTVPLGVF | 81 | Q96AA3 | |
| ISLWGSISFNLAVFI | 2226 | Q14571 | |
| GLIAFLQLTSTIITW | 596 | Q92621 | |
| NALLIFLIITSAWGG | 6 | P05546 | |
| QWLLIALPATFVNSA | 136 | P33897 | |
| SVLFLVVWLGLNVFL | 11 | Q9Y5S8 | |
| SLDLSTIIQGTWFLN | 636 | O75147 | |
| FDLALQGLQLLSQWS | 391 | Q7L576 | |
| WNAVLTLFVTSLIGA | 6 | Q9NWM8 | |
| SNNGLVTTLWFIFLL | 201 | Q8NGI4 | |
| ILGNVTLVLLISWDS | 41 | Q8NGR6 | |
| GWINSLLFVVIATLF | 36 | Q8NG84 | |
| SEQVLLLTLLGTLWG | 11 | Q9Y5G7 | |
| TDWALLLLQIITSGT | 1541 | Q86YW9 | |
| LLLTLLTQGTGSWAQ | 6 | A0A075B6J2 | |
| FSWLTLISEGAQLLQ | 256 | P60608 | |
| NLTTGATLINEQWLL | 126 | P00739 | |
| LKNSGVVSLDWAFLL | 1191 | Q6ZU64 | |
| SNALKVWGLELILFN | 81 | P54252 | |
| LLLWATLNAAFVLVG | 176 | P51798 | |
| TSLIRNGDWTFQILV | 176 | P05538 | |
| LLLTLLTQDTGSWAQ | 6 | P01705 | |
| QLWIGINFDRLTLLA | 981 | Q96RV3 | |
| QTWNGRLLAATFTLI | 286 | O43526 | |
| FWNLVTILVLQGRLD | 196 | Q9BW27 | |
| SLTLFGNTIIIALSW | 36 | Q8NGV0 | |
| SALGNGTILWIIALQ | 46 | Q8NGJ8 | |
| EFVLLGLSNSWGLQL | 11 | Q8NGD4 | |
| EFVLLGLSSSWELQL | 11 | Q8NH05 | |
| LTSASILAQQVWGTL | 326 | Q96PD5 | |
| ITETLTQFLGWSLLN | 421 | P51160 | |
| LWIIIAINFSNSGVK | 131 | Q4VXF1 | |
| GTQIVLLGLVTAALW | 21 | P06734 | |
| SALAANTLILIIIWQ | 46 | Q8NGI3 | |
| ALSLLAQWSTLVQEL | 416 | Q8WVB3 | |
| GVTRDFWVLNLTTLQ | 1591 | Q7Z7M0 | |
| GLASLNTLELFDNWL | 121 | Q9HBW1 | |
| WQGITNLKLIALTAS | 311 | P50748 | |
| LLLTLLTQGTGSWAQ | 6 | A0A075B6J9 | |
| WILSILCGTFQFQTL | 136 | Q92887 | |
| GSLQLWQFLVTLLDD | 366 | P41161 | |
| ELNISLTSIGLLWNI | 961 | Q7Z3U7 | |
| SVLLQVVELLGNFLW | 2726 | Q9Y4D8 | |
| IQLSLTLAALSIGLW | 131 | Q9Y5U4 | |
| LKGFNWTLFIQTVLS | 346 | Q495T6 | |
| LIGVLSSQISWCLLN | 21 | Q8NDY4 | |
| IIFVASILLNGLAVW | 51 | Q9BY21 | |
| WARQTFLLALLLGAT | 6 | P78509 | |
| SLNGGLSWSLLQEFL | 2251 | P78509 | |
| LWIIIAINFSNSGVK | 131 | A6NL05 | |
| QLRTGALFILNLWAS | 846 | Q96RW7 | |
| LLNQWLLSIVTGSIS | 191 | Q9UGF7 | |
| LTGILLNTLALWVFV | 56 | Q9BPV8 | |
| INTFLGVSTLLALWT | 221 | Q86UW1 | |
| QNNTWTLLGIGLAFL | 2071 | Q5VYJ5 | |
| IRINLGLWAASFILA | 151 | Q969V1 | |
| SVFTNLLLWANGVLN | 206 | Q7RTM1 | |
| SQLAWNSAVSLVLFV | 121 | P47804 | |
| NLVDWSSLNVLSVGL | 191 | Q9UM11 | |
| IAVLAIGLWLRFDSQ | 26 | P21926 | |
| FTIKVTGLAQVLLQW | 36 | Q01344 | |
| LFDTISLLIQGSLEW | 1931 | O43497 | |
| GLSSQQIFLWLQGLF | 1941 | Q8TD57 | |
| AAAWSILQQFLLSLT | 936 | P54289 | |
| LLFSLLAFVQGLVWN | 56 | Q96SL1 | |
| TWLTAFALRVLGQVN | 1076 | P01031 | |
| FGTTLLEISALWLQQ | 86 | Q6ZR85 | |
| LTWFINLFILSIENS | 3231 | Q8WXX0 | |
| LGFTLLLWSQVSGAQ | 36 | Q13007 | |
| GQWFLNQGTLLSLSE | 306 | Q9UBX1 | |
| DSLTSLQWLQEFSIL | 31 | Q92949 | |
| NLLEYGNITALTNLW | 3121 | Q99698 | |
| LLQLLAGAAFWITIA | 36 | Q9BSK0 | |
| SIFVILVWLGLNVFL | 11 | P04839 | |
| DIWAQSLVSLFQALR | 146 | Q6UWF9 | |
| TSSLISVQLLGVFIW | 706 | Q14831 | |
| SLFLQTALRGWAVQL | 221 | Q9H9S5 | |
| TALRGWAVQLLDLTF | 226 | Q9H9S5 | |
| VGLSFESVILWLNKN | 166 | P23945 | |
| QSSWNLLDGLLVLVS | 1361 | O95180 | |
| WLSLSRVNCSQFLGL | 31 | Q16667 | |
| VGSAVWQLIASFLRL | 96 | Q08357 | |
| NWQGIQLAITLPSFL | 266 | O75751 | |
| FGQWSSLLFSLVSLI | 196 | Q8NBW4 | |
| ILSALQDLFSVTWLN | 46 | Q96PD7 | |
| ISVLQWVLSFLVLGV | 71 | Q96PD7 | |
| WTLDSSQVLSINLFG | 296 | Q8WUT4 | |
| WTQLGLTFLQLLLIS | 6 | Q6UXH9 | |
| LLLTLLTQGTGSWAQ | 6 | P01704 | |
| FRLSNTVLGLTLLAW | 451 | Q6J4K2 | |
| ILLLTLTAQELSNSW | 176 | P03905 | |
| ELLMISNNGLLTTLW | 196 | Q8NGI6 | |
| SNNGLLTTLWFFLLL | 201 | Q8NGI6 | |
| DTLFSQWVALISLLN | 161 | Q8N9W8 | |
| YSIGLALSTLWNQLS | 141 | Q92990 | |
| LGLLNTKQLELWFSS | 601 | Q9BVN2 | |
| LNTSVVFGFLNLVLW | 201 | P08247 | |
| LGTFLLSILIAWTVQ | 1066 | Q68CR1 | |
| LLWSATILNIVGLFL | 221 | Q5JRV8 | |
| GLWNLVFLFSNLSLI | 111 | Q6UX01 | |
| LLLTLLTQGTGSWAQ | 6 | P01709 | |
| VWNVFLLANFTLVLS | 381 | Q7RTX9 | |
| SFTLFWEGQVSLSLL | 166 | Q6UWF7 | |
| FLVADSLINVWITLT | 716 | Q96NR3 | |
| GDLWRFQILQTVFLS | 11 | Q8IVM8 | |
| LALNAVTGFDLWLSV | 166 | Q9Y289 | |
| LIGTQNLFSLVLALW | 156 | Q9BY78 | |
| NLFSLVLALWDAVTG | 161 | Q9BY78 | |
| VGNFSLALIIFDWIN | 441 | Q8IZM9 | |
| VGWNIFDSLIVTLSL | 806 | Q15858 | |
| VLDLLWIASALSTGQ | 221 | Q16842 | |
| LSQGVQWSLLLAVLV | 11 | Q9NSC7 | |
| RIGLWSFDLTVTQLL | 466 | Q9NP59 | |
| LFGAVLQVFTLLWIA | 506 | Q96JW4 | |
| GSAWTILLLTENFLR | 131 | Q86XR7 | |
| LFQWLDSLQIDNLTS | 171 | Q9Y253 | |
| FATELGWLLLQESVL | 1361 | Q7RTU9 | |
| LSQVFWLAGSLLIIG | 176 | Q8N434 | |
| RLQWASLLLLFTGVA | 166 | P78381 | |
| NIAASLLVANTWFIV | 1056 | Q8IZF2 | |
| GLTSLFNLVVLAWAL | 421 | Q8IZF4 | |
| QLFLLQTVELGSWVG | 331 | A8K7I4 | |
| LLFVGLLLTWESGQV | 6 | P10909 | |
| VNLVVALLVGLSWLF | 361 | Q96Q45 | |
| KGLLTQVTQFWNLLD | 6 | Q8WWB5 | |
| VFLLSLVGNSLVLWV | 41 | P46094 | |
| SFWAQNIINLGSLVI | 411 | O15164 | |
| ALTVLLLQTLVVWNF | 21 | Q86Y38 | |
| LLQTLVVWNFSSLDS | 26 | Q86Y38 | |
| GQLWTNSLRIQYSLL | 101 | Q6ZTK2 | |
| DVQILLKLWSNGFSL | 141 | Q14CS0 | |
| LLWNFIVLLCRQNGT | 1536 | O15027 | |
| LGSFILLNVWINVVT | 31 | A0A1B0GUW6 | |
| LNQVTGLDIWASLLS | 156 | Q92911 | |
| EWNIILFSILITLSG | 156 | Q96CE8 | |
| LLWEVTTQSLLFLGK | 401 | Q86U17 | |
| AGWQSLLSFTILFLA | 66 | Q8TCJ2 | |
| WNVTDLIAILLFSVG | 966 | Q9HCF6 | |
| LLVVGNLVNWSFALF | 686 | Q9NXL6 | |
| LVVLLFSLWNQITCG | 441 | Q7Z404 | |
| NLSLFLSISLLIFWG | 221 | Q8N394 | |
| VNELLTSWLRGLVTF | 31 | Q96NG5 | |
| AVSLGTSDTLFLWLQ | 296 | O75191 | |
| EGISLLAQNTSWLLL | 131 | P04216 | |
| LSIWLSVIVFGNKIT | 336 | P0CK96 | |
| LWALDSLGQVFIRTL | 1181 | O15040 | |
| FSNTIEGLLFTWLLV | 176 | Q86VD9 | |
| VEWNVSLFSILLALG | 156 | P30408 | |
| FLGLVLWLSLDTSQR | 161 | O00337 | |
| VLSQWLGILATIAGL | 141 | Q8N357 | |
| WAVLAGNTTVISLLL | 231 | Q8IUH5 | |
| GFLSLLQVATFNGWI | 1131 | Q01118 | |
| TLQSLFWSVFGLLNL | 571 | Q9UL62 | |
| KGLLVTASLLNFWNL | 16 | P11465 | |
| WTIFLFLSNLRGDII | 266 | Q9H497 | |
| QNFGLKLLSWLGSII | 311 | Q8IWV8 | |
| LSLFLGNNTIRFTVW | 51 | Q6PJT7 | |
| ALAILLLQGLVVWSF | 21 | Q9H1B5 | |
| WQVFLLSASLNSFLV | 91 | Q2M3C6 | |
| ETLQSLFWSIFGLIN | 566 | Q9UBN4 | |
| AVFIFLWLQLDLVNG | 6 | A0A0B4J241 | |
| VWFVSLLALLGNVFV | 421 | P16473 | |
| DQRLLSQFGIWFLVS | 496 | Q9P2D8 | |
| VLIVSGNLSFLNWLT | 301 | Q96S06 | |
| QPFQSTLWLLVGLSV | 556 | Q05586 |